(Q33832517)

29 July 2017

title

Gene expression pathways of high grade localized prostate cancer (English)

1 reference

29 July 2017

1 reference

6

David M Berman

1 reference

29 July 2017

1

Ashley E Ross

1 reference

29 July 2017

7

Edward M Schaeffer

1 reference

29 July 2017

Luigi Marchionni

2

1 reference

29 July 2017

Milena Vuica-Ross

series ordinal

3

1 reference

29 July 2017

Chris Cheadle

series ordinal

4

1 reference

29 July 2017

Jinshui Fan

series ordinal

5

1 reference

29 July 2017

publication date

25 February 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

71

1 reference

29 July 2017

issue

14

1 reference

29 July 2017

page(s)

1568-1577

1 reference

29 July 2017

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Survival following primary androgen deprivation therapy among men with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Integrative molecular concept modeling of prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

A molecular correlate to the Gleason grading system for prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Novel targeted therapeutics for metastatic castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Identification of a tumour suppressor network opposing nuclear Akt function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Activation of Rap1 promotes prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Cancer stem cells: how can we target them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Genomic profiling of tumor initiating prostatospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Down-regulation of Jagged-1 induces cell growth inhibition and S phase arrest in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Stress-activated cap'n'collar transcription factors in aging and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Relaxin promotes prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

ABCC10, ABCC11, and ABCC12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Roles of the EZH2 histone methyltransferase in cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

PrLZ is expressed in normal prostate development and in human prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

PC-1/PrLZ contributes to malignant progression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Loss of HOXC6 expression induces apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

4E-BP1 is a target of Smad4 essential for TGFbeta-mediated inhibition of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

Multiple-laboratory comparison of microarray platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21373

21 January 2018

Identifiers

DOI

10.1002/PROS.21373

1 reference

29 July 2017

1 reference